The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global E. Coli testing market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 7.4% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Escherichia coli (E. Coli) testing refers to the process of detecting and monitoring the presence of foodborne pathogens. E. Coli bacteria is usually found in contaminated food and water, cheese manufactured from raw milk, undercooked products, unpasteurized milk and raw fruits and vegetables. It can cause various diseases, such as food poisoning, pneumonia and urinary tract infections (UTIs). Some of the clinical testing methods for the detection of E. Coli include enzyme immunoassays (EIA) and polymerase chain reaction (PCR) tests, along with environmental testing methods, such as enzyme-substrate, membrane filtration and multiple tube fermentation (MTF). These techniques aid in obtaining an accurate and quantitative measure of total coliform and bacteria present in the sample.
The increasing prevalence of water-borne diseases, such as diarrhea and hemolytic uremic syndrome (HUS), along with the growing need for clean potable water across the globe, is one of the key factors creating a positive outlook for the market. E. Coli tests can aid in monitoring the quality of surface and drinking water to prevent the spread of illnesses and diseases. Furthermore, the widespread adoption of the enzyme-substrate test as a presence or absence (P/A) test is also driving the market growth. These tests are easy to perform, do not require sophisticated laboratory equipment and use hydrolyzable fluorogenic substrates to detect the presence of various enzymes produced by the bacteria. Additionally, various technological advancements, such as the development of innovative bacterial diagnostic instruments and water testing methods, are contributing to the market growth. Other factors, including increasing health consciousness among the masses, along with extensive research and development (R&D) activities in the field of microbiology, are expected to drive the market further.
Breakup by Product:
Breakup by Test Type:
Breakup by End User:
Breakup by Region:
The report has also analysed the competitive landscape of the market with some of the key players being Accugen Laboratories Inc., Alere Inc. (Abbott Laboratories), BD (Becton Dickinson and Company), bioMérieux (INSTITUT MERIEUX), Bio-RAD Laboratories Inc., Enzo Life Sciences Inc. (Enzo Biochem Inc.), Idexx Laboratories Inc., Johnson & Johnson, Meridian Bioscience Inc., Nanologix Inc., Pro-Lab Diagnostics, Qiagen N.V. and Thermo Fisher Scientific Inc.
|Base Year of the Analysis||2020|
|Segment Coverage||Product, Test Type, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Accugen Laboratories Inc., Alere Inc. (Abbott Laboratories), BD (Becton Dickinson and Company), bioMérieux (INSTITUT MERIEUX), Bio-RAD Laboratories Inc., Enzo Life Sciences Inc. (Enzo Biochem Inc.), Idexx Laboratories Inc., Johnson & Johnson, Meridian Bioscience Inc., Nanologix Inc., Pro-Lab Diagnostics, Qiagen N.V. and Thermo Fisher Scientific Inc|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Key Questions Answered in This Report:
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at